Paula Cramer

Clinician scientist at Cologne University Hospital @UKKoeln and German CLL Study Group | Tweets are my own & no medical advice.

[Paula Cramer @PaulaCramer20]

@Othman_Al_Sawaf @dfg_public @UKKoeln @CECAD_ Congratulations! Very well deserved!

[Paula Cramer @PaulaCramer20]

@AjHematology @JTresckow @Othman_Al_Sawaf @HallekMichael @UKKoeln A huge thanks to @AjHematology for publishing this trial - it is really important to also report trials that did not meet their endpoint! @UKKoeln @HallekMichael @Othman_Al_Sawaf @JTresckow

[AmericanJournalofHematology @AjHematology]

The CLL2-BCG-trial by the German #CLL Study Group confirms the known severe toxicities of idelalisib and advise bendamustine followed by idelalisib and obinutuzumab should only be used with caution and if all other treatment options are exhausted https://t.co/RiSb1w0LrA #lymsm

[Paula Cramer @PaulaCramer20]

@HallekMichael @RomainGuieze

[Toby Eyre @tobyeyre82]

Reassessing the Chronic Lymphocytic Leukemia International Prognostic Index in the era of targeted therapies https://t.co/lkzt1iVURv

[DGHO e. V. @dgho_eV]

Medizinforschungsgesetz: Akademische Forschung bislang unberücksichtigt https://t.co/meaogWvEgm via @dt_aerzteblatt

[Paula Cramer @PaulaCramer20]

@UKKoeln @EKFStiftung @BroeckelmannPJ @MPIAGE Dear @BroeckelmannPJ congratulations, very well deserved!

[Paula Cramer @PaulaCramer20]

Thanks @ZDFheute for making us aware of these numbers on #February11 #InternationalDayofWomenandGirlsinScience! There is still a long way! @WomenInLymphoma @UKKoeln

[ZDFheute @ZDFheute]

Frauen in der Wissenschaft: Nur ein Drittel der Forschenden sind Frauen https://t.co/WN3nr7rT5D

[ZDFheute @ZDFheute]

Frauen in der Wissenschaft: Nur ein Drittel der Forschenden sind Frauen https://t.co/WN3nr7rT5D

[Paula Cramer @PaulaCramer20]

@DimHien @vomSteinA @HallekMichael Congratulations! Looking forward to working with you on our next phase-I/II trials which will tackle the microenvironment in CLL!

[Richard Buka 💙 @richardbuka]

Top trials/studies/advances in non-malignant haematology in 2023. Note, I have not offered much critique here.

Some trials are better than others!

A🧵

[Paula Cramer @PaulaCramer20]

@FlorianHeidel @UMGreifswald Congratulations on a great presentation and important work!

[Paula Cramer @PaulaCramer20]

@Othman_Al_Sawaf @NatureMedicine Congratulations @Othman_Al_Sawaf on a great presentation and this publication!

[Michael Makris @ProfMakris]

The World Health Organisation (@WHO) has got it wrong when recommending products for #hemophilia, and this is potentially dangerous for persons in low income countries. 1/6

[Paula Cramer @PaulaCramer20]

@schumacherbj @CornelyOliver +1

[Björn Schumacher @schumacherbj]

More than 1000 scientists in Germany have by now signed this open letter against antisemitism and for democracy, freedom and human rights.

[David Steensma, MD @DavidSteensma]

Truth matters. I found this @JCO_ASCO essay by Dr Hellman, "Gift of Truth", moving. She describes how her father was able to make his last days count - he called all his old research collaborators to say thank you! - because of his oncologist's honesty.❤️ https://t.co/BTgo5wwILF

[Philipp Grätzel von Grätz @dukla_DE]

Deprimierendes Slide von @HallekMichael heute Herbsttagung #VisionZero. Klinische Studien weltweit, gelb wissenschaftsinitiiert, blau pharma-sponsored. Entscheidend jeweils letzte Spalte „pro 1 Million Einwohner“. Man muss schon suchen, um ein Land zu finden, das weniger schafft.

[Bundesministerium für Wirtschaft und Energie @BMWE_]

Der Terrorangriff der Hamas auf #Israel ist jetzt bald vier Wochen her. Vieles ist seitdem passiert, die öffentliche Debatte aufgeheizt und verworren. Im Video deshalb einige Gedanken von Vizekanzler und Minister Robert #Habeck zur Einordnung und Differenzierung.